Symptoms of myeloproliferative neoplasms (MPNs) have a large impact on quality of life for patients and it is important to be able to link them, said Ruben Mesa, MD, director of UT Health San Antonio MD Anderson Cancer Center.
Symptoms of myeloproliferative neoplasms (MPNs) have a large impact on quality of life for patients and it is important to be able to link them, said Ruben Mesa, MD, director of UT Health San Antonio MD Anderson Cancer Center.
Transcript
What is the quality of life model your team developed for patients with myeloproliferative neoplasms? What does it utilize and how does it gauge quality of life?
So, our team had looked at a range of data that we have acquired over the time with survey research looking at mathematical models of quality of life and drivers of quality of life. Looking at age, looking at comorbidities, looking at MPN-related symptoms.
What we found, interestingly, is the MPN symptoms were one of the primary drivers of the health-related quality of life for patients—even more so than age, even more so than comorbidities, even significant comorbidities. So, I think many reasons for that: the symptoms are both difficult but they’re incredibly chronic.
So, if you have difficult itching that is almost 24/7, you can imagine what an impact that has on you. Or if you have splenomegaly and really can’t find a comfortable position to sleep, and have chronic insomnia, that takes an enormous impact on your quality of life in a very rapid way. So, that mathematical model helps to demonstrate aspects of that and that important linkage analysis.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
2 Commerce Drive
Cranbury, NJ 08512